ArticleJournal of hematology & oncology2020

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.

Manman Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.